Multi-detector row CT angiography of pulmonary circulation with gadolinium-based contrast agents: Prospective evaluation in 60 patients

Radiology

Volumn 238, Issue 3, 2006, Pages 1022-1035

  Remy Jardin, Martine ^a   Bahepar, Julbert ^a   Lafitte, Jean Jacques ^a   Dequiedt, Philippe ^a   Ertzbischoff, Olivier ^b   Bruzzi, John ^a   Delannoy Deken, Valérie ^c   Duhamel, Alain ^c   Remy, Jacques ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Schering SA   (France)

^c UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM CHELATE; GADOLINIUM PENTETATE; IODINE;

ADULT; AGED; ANAPHYLAXIS; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CONVULSION; DIAGNOSTIC VALUE; DRUG SAFETY; FEMALE; FLUSHING; HEADACHE; HUMAN; IMAGE QUALITY; INJECTION SITE PAIN; INJECTION SITE WARMTH; KIDNEY FUNCTION; LUNG CIRCULATION; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHIC ANGIOGRAPHY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY; SIDE EFFECT; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANGIOGRAPHY; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; PULMONARY CIRCULATION; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33344477027     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2382042100     Document Type: Article

References (32)

1. Ley S, Kreitner KF, Fink C, Heussel CP, Borst MM, Kauczor HU. Assessment of pulmonary hypertension by CT and MR imaging. Eur Radiol 2004;14:359-368.
2. Kauczor HU, Kreitner KF. MRI of the pulmonary parenchyma. Eur Radiol 1999;9:1755-1764.
3. Bloem JL, Wondergem J. Gd-DTPA as a contrast agent in CT. Radiology 1989;171:578-579.
4. Coche EE, Hammer FD, Gofette PP. Demonstration of pulmonary embolism with dynamic gadolinium-enhanced spiral CT. Eur Radiol 2001;11:2306-2309.
5. Remy-Jardin M, Dequiedt P, Ertzbischoff O, et al. Safety and effectiveness of gadolinium-enhanced multi-detector row spiral CT angiography of the chest: preliminary results in 37 patients with contraindications to iodinated contrast agents. Radiology 2005;235:819-826.
6. Palmer BF, Henrich WL. Toxic nephropathy. In: Brenner BM, Levine SA, eds. Brenner & Rector's the kidney. 7th ed. Philadelphia, Pa: Saunders, 2004;1625-1658.
7. Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol 2004;183:1673-1689.
8. Schmitz SA, Wagner S, Schuhmann-Giampieri G, Wolf KJ. Evaluation of gadobutrol in a rabbit model as a new lanthanide contrast agent for computed tomography. Invest Radiol 1995;30:644-649.
9. Kawano T, Ishijima H, Nakajima T, Aoki J, Endo K. Gd-DTPA: a possible alternative contrast agent for use in CT during intraarterial administration. J Comput Assist Tomogr 1999;23:939-940.
10. Remy-Jardin M, Remy J, Wattinne L, Giraud F. Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single breath hold technique-comparison with pulmonary angiography. Radiology 1992;185:381-387.
11. Shellock FG, Kanal E. Safety of magnetic resonance imaging contrast agents. J Magn Reson Imaging 1999;10:477-484.
12. Lautin EM, Freeman NJ, Schoenfeld AH, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. AJR Am J Roentgenol 1991;157:49-58.
13. Thomsen HS. Guidelines for contrast media from the European Society of Urogenital Radiology. AJR Am J Roentgenol 2003;181:1463-1471.
14. Qanadli SD, Hajjam ME, Mesurolle B, et al. Pulmonary embolism detection: prospective evaluation with dual-detector row helical CT versus selective pulmonary arteriography in 157 patients. Radiology 2000;217:447-455.
15. Ghaye B, Szapiro D, Mastora I, et al. Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis? Radiology 2001;219:629-636.
16. Schoepf UJ, Holzknecht N, Helmberger TK, et al. Subsegmental emboli: improved detection with thin-collimation multi-detector row spiral CT. Radiology 2002;222:483-490.
17. Niendorf HP, Haustein J, Louton AT, et al. Safety and tolerance after intravenous administration of 0.3 mmol/kg Gd-DTPA: results of a randomized, controlled clinical trial. Invest Radiol 1991;26(suppl 1):S221-S223.
18. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imaging 1996;6:162-166.
19. Swan SK, Baker JF, Free R, et al. Pharmacokinetics, safety, and tolerability of gadoversetamide injection (Optimark) in subjects with central nervous system or liver pathology and varying degrees of renal function. J Magn Reson Imaging 1999;9:317-321.
20. Pena CS, Kaufman JA, Geller SC, Waltman AC. Gadopentetate dimeglumine: a possible alternative contrast agent for CT angiography of the aorta. J Comput Assist Tomogr 1999;23:23-24.
21. Luboldt W, De Santis M, von Smekal A, Reiser M. Attenuation characteristics and application of gadolinium-DTPA in fast helical computed tomography. Invest Radiol 1997;32:690-695.
22. Havron A, Davis M, Seltzer S, Paskin-Hurlburt A, Hessel S. Heavy metal particulate contrast materials for computed tomography of the liver. J Comput Assist Tomogr 1980;4:642-648.
23. Seltzer SE, Adams DF, Davis MA, et al. Hepatic contrast agents for computed tomography: high atomic number particulate material. J Comput Assist Tomogr 1981;5:370-374.
24. Unger E, Guttierez F. Ytterbium-DTPA: a potential intravascular contrast agent. Invest Radiol 1986;21:802-807.
25. Strunk HM, Schild H. Actual clinical use of gadolinium-chelates for non-MRI applications. Eur Radiol 2004;14:1055-1062.
26. Albrecht T, Dawson P. Gadolinium-DTPA as x-ray contrast medium in clinical studies. Br J Radiol 2000;73:878-882.
27. Thurnher SA, Capelastegui A, Herraiz Del Olmo F, et al. Safety and effectiveness of single- versus triple-dose gadodiamide injection-enhanced MR angiography of the abdomen: a phase III double-blind multicenter study. Radiology 2001;219:137-146.
28. Haustein J, Niendorp HP, Krestin G, et al. Renal tolerance of Gd-DTPA dimeglumine in patients with chronic renal failure. Invest Radiol 1992;27:153-156.
29. Tombach B, Bremer C, Reimer P, et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: results of a randomized study. Radiology 2001;218:651-657.
30. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420.
31. Tepel M, Van der Giet M, Schwarzfeld C, Laufer U, Lierman D, Zidek W. Prevention of radiographic-contrast-agent-induced reactions in renal function by acetylcysteine. N Engl J Med 2000;343:180-184.
32. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348:491-499.